Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers

NCT02245451 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tipranavir
DRUG: Ritonavir
DRUG: Methadone

Sponsor

Boehringer Ingelheim